S100A9 and peripheral arterial disease: Genetic RNA sequencing of platelets from CVD patients allows the identification of new mediators in MPA formation and monocyte reprogramming: Platelets from patients with symptomatic PAD were enriched with myeloid-related protein-14 (MRP-14) mRNA and protein.